Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry-Reference-Cited by-同舟云学术

Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry

Published:2023-11-01 Issue:11 Volume:25 Page:774-781
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Biester Torben¹^ORCID,Eckert Alexander²³,Becker Marianne⁴^ORCID,Boettcher Claudia⁵^ORCID,Golembowski Sven⁶,Heidtmann Bettina⁷^ORCID,Klinkert Christoph⁸,Müther Silvia⁹,Rami-Merhar Birgit¹⁰^ORCID,Holl Reinhard W.²³^ORCID,

Affiliation:

1. AUF DER BULT, Diabetes Center for Children and Adolescents, Hannover, Germany.

2. University of Ulm, Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm, Germany.

3. German Center for Diabetes Research e.V., Munich-Neuherberg, Germany.

4. Centre Hospitalier de Luxembourg, DECCP, Luxembourg, Luxembourg.

5. Department of Paediatrics, Division of Paediatric Endocrinology, Diabetology & Metabolism, University of Bern, Bern University Hospital, Inselspital, Bern, Switzerland.

6. Sana Klinikum Lichtenberg, Diabetes Center for Children and Adolescents, Berlin, Germany.

7. Catholic Children's Hospital Wilhelmstift, Hamburg, Germany.

8. Pediatric Practice, Herford, Germany.

9. DRK Kliniken Berlin Westend, Diabetes Center for Children and Adolescents, Berlin, Germany.

10. Department of Pediatric and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0283

Reference38 articles.

1. Insulinpumpe, kontinuierliche und kapilläre Glukosemessung bei Kindern, Jugendlichen und Erwachsenen mit Diabetes mellitus: Daten des DPV-Registers zwischen 1995 und 2019

2. Use of Continuous Glucose Monitoring in Pump Therapy Sensor Augmented Pump or Automated Insulin Delivery in Different Age Groups (0.5 to <26 Years) With Type 1 Diabetes From 2018 to 2021: Analysis of the German/Austrian/Swiss/Luxemburg DPV Registry

3. Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review

4. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus